China Nuokang Bio-Pharmaceutical Inc. to Report Second Quarter 2011 Financial Results

BEIJING, Aug. 17, 2011 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that the Company plans to release second quarter 2011 financial results on Thursday, August 25, 2011 after the market closes.

The Company will hold a conference call at 8:00 am ET on Friday, August 26, 2011 to discuss second quarter 2011 results. Listeners may access the call by dialing:

United States toll free:1-866-405-2350
United States toll:1-718-354-1231
China toll free: 400-6988181
Hong Kong toll free: 800-965084
United Kingdom toll free:0800-0322281
Conference ID:91498737

A telephone replay will be available beginning two hours after the conclusion of the call and will be available through September 7, 2011. Listeners may access the replay by dialing:

United States toll free:1-866-214-5335
International: 1-718-354-1232
Conference ID:91498737

A webcast will also be available through the Company's website www.nkbp.com. 

About China Nuokang Bio-Pharmaceutical Inc.

China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) is a leading biopharmaceutical company in China focused on the research, development, manufacture, marketing and sales of hospital-based medical products. The Company provides a diversified portfolio of products across more than 2,400 hospitals in China. Nuokang's principal products include Baquting®, China's leading hemocoagulase product by market share, and Kaitong®, a lipid emulsion alprostadil product for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. The Company's product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention.www.nkbp.com for more information. 

CONTACT: ICR, Inc.

         In the U.S.: Ashley M. Ammon: 1-646-277-1227

         In China: Wen Lei Zheng: 86-10-6583-7510
Source: China Nuokang Bio-Pharmaceutical Inc.